Market Trends of CPAP Devices Industry
Sleep Apnea Segment Expected to Witness Significant Growth Over the Forecast Period
The sleep apnea segment is expected to witness significant growth in the CPAP devices market over the forecast period owing to the growing burden of sleep apnea among the population, the rising number of studies evaluating the potential of CPAP devices in sleep apnea, and new product launches by the key players in the market.
In France, multiple studies have evaluated the efficacy of Continuous Positive Airway Pressure (CPAP) treatment for obstructive sleep apnea (OSA). For instance, a November 2024 article published in Respiratory Medicine and Research highlighted that, when compared to the general population with undiagnosed and untreated OSA, those receiving CPAP treatment experienced lower healthcare costs in the year following treatment initiation. This underscores the importance of improving access to OSA diagnosis and treatment for the broader population.
Furthermore, the rising launches of new products by key players are expected to fuel the availability of advanced CPAP devices in the market. This, in turn, is anticipated to bolster the segment’s growth over the forecast period. For instance, in March 2024, ResMed unveiled the AirFit F40, an ultra-compact full-face mask designed for sleep apnea. This innovative mask combines the comfort of smaller models with top-notch performance. Highlighting its standout feature, the AdaptiSeal cushion, the company emphasized its 100% soft silicone material, ensuring a reliable facial seal. Additionally, the mask boasts a quick-release short tube, minimizing tube drag and facilitating easy detachment and reattachment throughout the night.
Similarly, in June 2023, Airway Management launched its Morf Nasal CPAP mask, prioritizing both comfort and sustainability. This innovative mask features a silicone-free biodegradable seal, establishing a new industry benchmark. Tailored to individual facial structures and contours, it ensures an optimal and comfortable fit. Consequently, these advancements are expected to drive greater adoption of these masks among the target population, thereby propelling the segment’s growth.
Therefore, owing to factors such as new product launches and the growing number of research studies related to CPAP devices in sleep apnea, the segment studied is anticipated to grow over the forecast period.
North America Expected to Hold a Significant Market Share Over the Forecast Period
North America is expected to witness significant growth over the forecast period owing to factors such as the growing burden of respiratory diseases and sleep disorders among the population, technological advancements in CPAP devices, and new product launches by key players in the market. In addition, the growing government initiatives to launch various sleep-related awareness programs in the region are further anticipated to drive market growth over the forecast period.
The high prevalence of sleep disorders among the population is the key factor driving the demand for CPAP devices in the region, propelling market growth. For instance, as per the Sleep Apnea data published by the National Council on Aging in May 2024, about 936 million adults worldwide are estimated to have mild to severe obstructive sleep apnea (OSA), including approximately 39 million US adults who had OSA during 2021-2022. Thus, the increasing prevalence of sleep apnea created a demand for advanced devices that prevent apnea episodes and improve sleep quality. This, in turn, is anticipated to propel the growth of CPAP devices in the market.
Additionally, there is an increase in awareness among consumers about sleep apnea or sleep disorders and supportive initiatives launched by the government in the United States, which is expected to propel the market’s growth over the forecast period. For instance, according to an article published by the Center for Disease Control and Prevention (CDC) in December 2022, the CDC awarded a three-year grant (2021-2024) for the National Healthy Sleep Awareness Project. The project would focus on expanding education and awareness of obstructive sleep apnea. Hence, the rising awareness among the people in the country with government initiatives and support would drive the demand for CPAP devices in the US market, thereby boosting the market’s growth.
Furthermore, the rising new product launches by key players are anticipated to fuel the availability of innovative CPAP devices in the market, hence bolstering market growth. For instance, in April 2024, Fisher & Paykel Healthcare Corporation Limited launched the F&P Solo Nasal mask in the United States for the treatment of obstructive sleep apnea (OSA). AutoLock technology holds the mask in place with minimal force and dynamically responds to sleep movement and CPAP-therapy pressure. It is an intuitive, innovative, and first-of-a-kind product.
Moreover, in February 2024, ResMed introduced its latest AirCurve 11 series of bilevel-positive airway pressure devices in the United States. The AirCurve 11 series employs two levels of support: inspiratory positive airway pressure (IPAP) and expiratory positive airway pressure (EPAP). Enhanced with digital technology, the AirCurve 11 aims to assist providers in effectively treating sleep apnea, ensuring patients not only begin but also remain on their therapy. Thus, the development of such advanced devices is expected to propel their adoption by patients, which, in turn, is anticipated to augment the market’s growth over the forecast period.
Therefore, owing to the high burden of sleep apnea, rising government initiatives to launch awareness programs, and new product launches by key players, the market studied is expected to grow over the forecast period.
